Afficiency Secures $7.0M

MigmaAI

Create, design and send on-brand emails in seconds.

Parcel Health

Healthcare and pharmacies' supply chain runs on expensive plastic. Billions of units of disposable, single-use supplies and packaging — most of it never questioned, never redesigned, never replaced. Paid for at a premium to budgets and to the environment. Until now. Parcel Health is reimagining healthcare supplies, creating products that can protect people and preserve the planet, all at an affordable price point. Tully Tube® is the world's first and only paper pill bottle that meets U.S. regulatory requirements. It is trusted by leading hospital health-systems like Dartmouth-Hitchcock Health System, Allegheny Health Network, and Wellstar Health System. This is just the beginning. Parcel Health is building a future where healthcare supplies are safer for patients, better for the planet, and easier on budgets.

Chromie Health

Meet Chromie, the future of hospital workforce automation. As seen in Forbes 30 Under 30, Chromie Health is revolutionizing hospital staffing and administration with AI-powered automation. Our platform seamlessly integrates with systems like ADT and Epic, replacing outdated manual processes with real-time, data-driven workforce management. Chromie generates optimal schedules in a single click, reducing nurse scheduling time by 8 hours per week and cutting annual staffing costs by $320K per unit. Chromie isn’t just another scheduling tool; it’s the first of many AI-driven solutions designed to transform hospital operations. By enhancing workforce efficiency, improving patient outcomes, and automating complex workflows, Chromie empowers hospitals to stay ahead of the growing demand for smarter, scalable solutions. With seamless 6-8 week integration, HIPAA-compliant AI that works with existing tech stacks, and proven success, Chromie Health is leading the charge in redefining healthcare workforce management, saving hospitals time, money, and lives.

Degron Therapeutics

Degron Therapeutics aims to become a global leader in the discovery and development of a new class of targeted protein degradation therapeutics, small molecule molecular glue degrader (MGD) drugs. Degron has assembled a team of world-class executives and scientific leaders, bringing its scientific excellence to the identification and validation of disease targets, particularly those undruggable by conventional small molecule inhibitors, and novel selective MGD compounds to meet unmet medical needs in all therapeutic areas.

Exponent

Exponent is the first financial technology platform built for QSRs and franchise operators, providing industry-specific credit cards, automated spend management, and flexible financing solutions. Our mission is to help franchisees maximize cash back, streamline financial operations, and unlock growth with fast, transparent funding—all in one seamless platform. With Exponent, franchise owners can earn more on essential expenses, access capital faster than banks or SBA loans, and gain real-time visibility into their financial health. Backed by some of the largest QSR franchisees in the U.S., Exponent is revolutionizing how operators manage and scale their businesses. Join the future of franchise finance.